I. Nakamura

NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel

K. Kataoka, Y. Matsumura, T. Hamaguchi, 2005, British Journal of Cancer.

An in vivo mechanism for the reduced peripheral neurotoxicity of NK105: a paclitaxel-incorporating polymeric micellar nanoparticle formulation

T. Onda, Hitomi Hayashi, D. Nagai, 2017, International Journal of Nanomedicine.